Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RPS6KA5 | O75582 | 1/20 | 0.39 |
| ▸ | ROCK1 | Q13464 | 5/20 | 0.35 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.33 |
| ▸ | CDC7 | O00311 | 5/20 | 0.33 |
| ▸ | CDK2 | P24941 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.32 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28606708 | 0.82 | RPS6KA5 (0.40) | RPS6KA5KDM4EPOLBCTDSP1 | |
| SCHEMBL28608545 | 0.79 | HPGD (0.36) | RPS6KA5KDM4EPOLBCTDSP1 | |
| SCHEMBL19100339 | 0.78 | RARG (0.35) | RPS6KA5POLB | |
| SCHEMBL28605367 | 0.78 | PIN1 (0.38) | KDM4E | |
| SCHEMBL28607844 | 0.75 | RPS6KA5 (0.40) | RPS6KA5KDM4EPOLB | |
| SCHEMBL28600565 | 0.74 | RPS6KA5 (0.46) | RPS6KA5ROCK1TRPV1CDC7CDK2 | |
| SCHEMBL17339100 | 0.73 | RPS6KA5 (0.50) | RPS6KA5ROCK1CDC7CDK2KDM4E | |
| SCHEMBL30467968 | 0.73 | RPS6KA5 (0.50) | RPS6KA5ROCK1CDC7CDK2KDM4E | |
| SCHEMBL19100158 | 0.73 | RPS6KA5 (0.52) | RPS6KA5ROCK1TRPV1CDC7CDK2 | |
| SCHEMBL19100727 | 0.72 | RPS6KA5 (0.46) | RPS6KA5ROCK1TRPV1CDC7CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109328059-B | Selective inhibitors of clinically important mutants of EGFR tyrosine kinase | CS制药技术有限公司 | 2021-08-17 | — | — | CN | disclosed |
| CN-109328059-A | Selective inhibitors of clinically important mutants of EGFR tyrosine kinase | CS制药技术有限公司 | 2019-02-12 | — | — | CN | disclosed |